Andrew P. Brogan, Ph.D. - Publications
Affiliations: | 2004 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
biological mechanisms of therapeutic agentsYear | Citation | Score | |||
---|---|---|---|---|---|
2005 | Brogan AP, Widger WR, Bensadek D, Riba-Garcia I, Gaskell SJ, Kohn H. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry. Journal of the American Chemical Society. 127: 2741-51. PMID 15725032 DOI: 10.1021/Ja046441Q | 0.543 | |||
2005 | Brogan AP, Verghese J, Widger WR, Kohn H. Bismuth-dithiol inhibition of the Escherichia coli rho transcription termination factor. Journal of Inorganic Biochemistry. 99: 841-51. PMID 15708806 DOI: 10.1016/J.Jinorgbio.2004.12.019 | 0.508 | |||
2005 | Skordalakes E, Brogan AP, Park BS, Kohn H, Berger JM. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin. Structure (London, England : 1993). 13: 99-109. PMID 15642265 DOI: 10.1016/J.Str.2004.10.013 | 0.554 | |||
2003 | Brogan AP, Widger WR, Kohn H. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties. The Journal of Organic Chemistry. 68: 5575-87. PMID 12839449 DOI: 10.1021/Jo030020U | 0.542 | |||
Show low-probability matches. |